BVF PARTNERS L P Transaction History

Date Transaction Value Shares Traded Form
Jun 26 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$14,280,502 $9.1 p/Share
1,569,286
Aug 09 2022
SELL
Open market or private sale
$7,891,336 $6.12 p/Share
1,289,434
Aug 09 2022
BUY
Conversion of derivative security
-
1,519,999
Feb 09 2018
SELL
Sale (or disposition) back to the issuer
-
1,487,294
Feb 09 2018
BUY
Open market or private purchase
$2,097,675 $3.0 p/Share
699,225

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
CNCE
CONCERT PHARMACEUTICALS, INC. Healthcare
XENE
Xenon Pharmaceuticals Inc. Healthcare
ARQL
ARQULE INC
SNDX
Syndax Pharmaceuticals Inc Healthcare
XOMA
XOMA Corp Healthcare
IMDZ
IMMUNE DESIGN CORP.
PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
GLYC
GLYCOMIMETICS INC Healthcare
FPRX
FIVE PRIME THERAPEUTICS, INC.
CALA
Calithera Biosciences, Inc. Healthcare
CYTK
CYTOKINETICS INC Healthcare
MRUS
Merus N.V. Healthcare
IDYA
IDEAYA Biosciences, Inc. Healthcare
PRNB
Principia Biopharma Inc.
KYMR
Kymera Therapeutics, Inc. Healthcare
OLMA
Olema Pharmaceuticals, Inc. Healthcare
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
RAIN
Rain Therapeutics Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
CGEM
Cullinan Oncology, Inc. Healthcare
THRD
Third Harmonic Bio, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
MLTX
MoonLake Immunotherapeutics Healthcare
PNT
POINT Biopharma Global Inc. Healthcare
BPL

Bvf Partners L P

Director
San Francisco, CA

Track Institutional and Insider Activities on CTIC

Follow CTI BIOPHARMA CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTIC shares.

Notify only if

Insider Trading

Get notified when an Cti Biopharma Corp insider buys or sells CTIC shares.

Notify only if

News

Receive news related to CTI BIOPHARMA CORP

Track Activities on CTIC